888-969-2592
Kalkine 0
countryflagCA
L

RY 160.56 -0.1493% SHOP 117.49 0.1022% TD 83.8 0.2872% ENB 62.22 0.7122% BN 68.21 -0.9008% TRI 254.25 0.197% CNQ 39.38 3.062% CP 101.78 -1.1173% CNR 136.4 -0.8144% BMO 128.57 -0.6721% BNS 65.55 0.0305% CSU 4671.2002 0.149% CM 81.67 0.2086% MFC 39.79 -1.7288% ATD 69.75 0.2011% NGT 77.82 2.1528% TRP 68.1 0.3981% SU 47.09 1.2688% WCN 275.42 0.6431% L 211.26 0.3039%
RY 160.56 -0.1493% SHOP 117.49 0.1022% TD 83.8 0.2872% ENB 62.22 0.7122% BN 68.21 -0.9008% TRI 254.25 0.197% CNQ 39.38 3.062% CP 101.78 -1.1173% CNR 136.4 -0.8144% BMO 128.57 -0.6721% BNS 65.55 0.0305% CSU 4671.2002 0.149% CM 81.67 0.2086% MFC 39.79 -1.7288% ATD 69.75 0.2011% NGT 77.82 2.1528% TRP 68.1 0.3981% SU 47.09 1.2688% WCN 275.42 0.6431% L 211.26 0.3039%

small-cap

Technical Analysis on One NASDAQ- Listed Biotechnology Stock- DWTX

Mar 10, 2025 | Team Kalkine
Technical Analysis on One NASDAQ- Listed Biotechnology Stock- DWTX
Image source: shutterstock

DWTX:NASDAQ
Investment Type
Small-Cap
Risk Level
Action
Rec. Price (US$)

Dogwood Therapeutics, Inc. (NASDAQ: DWTX)

Dogwood Therapeutics, Inc. (NASDAQ: DWTX) formerly Virios Therapeutics, Inc., is focused on the clinical development of three assets, Halneuron, IMC-1, and IMC-2. Halneuron is in Phase 2b development as a non-opioid, Nav 1.7 inhibitor, to treat the neuropathic pain associated with chemotherapy treatment.

Technical Observation (on the daily chart): 

Xxxxxx Xxxxxx Xxxxxx

Xxxxxx Xxxxxx

Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .

Xxxxxx Xxxxxx Xxxxxx Xxxxxx & Xxxxxx

  • Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx
  • Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .

Xxxxxx Xxxxxx

Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .

Xxxxxx

Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .   

Interested?

Enter your details below and our team will help you to decide if this product is best for you.
  • Australia+61
  • Canada+1
  • India (भारत)+91
  • New Zealand+64
  • United Kingdom+44
  • United States+1
By submitting your details and clicking on the button below, you agree to Kalkine’s Terms and Conditions and agree to receive marketing offers, including to be contacted by email or phone, as set out in our Privacy Policy
Please wait processing your request...
Disclaimer-

The advice given by Kalkine Canada Advisory Services Inc. and provided on this website is general information only and it does not take into account your investment objectives, financial situation and the particular needs of any particular person. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. The website www.kalkine.ca is published by Kalkine Canada Advisory Services Inc. The link to our Terms & Conditions has been provided please go through them. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.

Small-Cap
How is Needle Moving in One NYSE Listed Energy Stock – PARR
Apr 16, 2025 Team Kalkine
Small-Cap
One NASDAQ - Listed Food Products Stock Under Radar - BYND
Apr 16, 2025 Team Kalkine
Small-Cap
One NYSE Listed Oil & Gas Drilling Stock Under Radar – BORR
Apr 16, 2025 Team Kalkine
Small-Cap
Technical Analysis on One NASDAQ- Listed Biotechnology Stock- ACET
Apr 16, 2025 Team Kalkine
Small-Cap
Technical Analysis on One NASDAQ- Listed Business Support Services Stock- STBX
Apr 16, 2025 Team Kalkine